A Case of Severe Acute Gastritis as an Immune-Related Adverse Event After Nivolumab Treatment: Endoscopic and Pathological Findings in Nivolumab-Related Gastritis

Dig Dis Sci. 2021 Jul;66(7):2461-2465. doi: 10.1007/s10620-020-06529-3. Epub 2020 Aug 11.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Endoscopy, Gastrointestinal*
  • Gastritis / chemically induced*
  • Gastritis / drug therapy
  • Gastritis / pathology*
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Nivolumab / adverse effects*
  • Nivolumab / therapeutic use
  • Prednisone / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Immune Checkpoint Inhibitors
  • Nivolumab
  • Prednisone